BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 34757808)

  • 21. Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation.
    Hams E; Colmont CS; Dioszeghy V; Hammond VJ; Fielding CA; Williams AS; Tanaka M; Miyajima A; Taylor PR; Topley N; Jones SA
    J Immunol; 2008 Aug; 181(3):2174-80. PubMed ID: 18641356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
    West NR; Hegazy AN; Owens BMJ; Bullers SJ; Linggi B; Buonocore S; Coccia M; Görtz D; This S; Stockenhuber K; Pott J; Friedrich M; Ryzhakov G; Baribaud F; Brodmerkel C; Cieluch C; Rahman N; Müller-Newen G; Owens RJ; Kühl AA; Maloy KJ; Plevy SE; ; Keshav S; Travis SPL; Powrie F
    Nat Med; 2017 May; 23(5):579-589. PubMed ID: 28368383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensory neuronal STAT3 is critical for IL-31 receptor expression and inflammatory itch.
    Takahashi S; Ochiai S; Jin J; Takahashi N; Toshima S; Ishigame H; Kabashima K; Kubo M; Nakayama M; Shiroguchi K; Okada T
    Cell Rep; 2023 Dec; 42(12):113433. PubMed ID: 38029739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catechins inhibit CXCL10 production from oncostatin M-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakanishi T; Nakae H; Matsuo T
    J Nutr Biochem; 2010 Jul; 21(7):659-64. PubMed ID: 19616927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis.
    Komori T; Hisaoka T; Kotaki A; Iwamoto M; Miyajima A; Esashi E; Morikawa Y
    FASEB J; 2024 Jan; 38(1):e23359. PubMed ID: 38102969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncostatin-M Does Not Predict Treatment Response in Inflammatory Bowel Disease in a Pediatric Cohort.
    Ezirike Ladipo J; He Z; Chikwava K; Robbins K; Beri J; Molle-Rios Z
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):352-357. PubMed ID: 34117193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hierarchical Specification of Pruriceptors by Runt-Domain Transcription Factor Runx1.
    Qi L; Huang C; Wu X; Tao Y; Yan J; Shi T; Cao C; Han L; Qiu M; Ma Q; Liu Z; Liu Y
    J Neurosci; 2017 May; 37(22):5549-5561. PubMed ID: 28476948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
    Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
    Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
    Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
    Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New mechanism underlying IL-31-induced atopic dermatitis.
    Meng J; Moriyama M; Feld M; Buddenkotte J; Buhl T; Szöllösi A; Zhang J; Miller P; Ghetti A; Fischer M; Reeh PW; Shan C; Wang J; Steinhoff M
    J Allergy Clin Immunol; 2018 May; 141(5):1677-1689.e8. PubMed ID: 29427643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology.
    Hermanns HM
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):545-58. PubMed ID: 26198770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensory neuron-expressed TRPC3 mediates acute and chronic itch.
    Liu Y; Liu Y; Limjunyawong N; Narang C; Jamaldeen H; Yu S; Patiram S; Nie H; Caterina MJ; Dong X; Qu L
    Pain; 2023 Jan; 164(1):98-110. PubMed ID: 35507377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.
    West NR; Murphy LC; Watson PH
    Endocr Relat Cancer; 2012 Apr; 19(2):181-95. PubMed ID: 22267707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts.
    Foglia B; Sutti S; Pedicini D; Cannito S; Bocca C; Maggiora M; Bevacqua MR; Rosso C; Bugianesi E; Albano E; Novo E; Parola M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons.
    Sun PY; Li HG; Xu QY; Zhang Z; Chen JW; Shen YH; Qi X; Lu JF; Tan YD; Wang XX; Li CX; Yang MY; Ma YZ; Lu Y; Xu TL; Shen JW; Li WG; Guo YF; Yao ZR
    Br J Pharmacol; 2023 May; 180(10):1339-1361. PubMed ID: 36521846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nppb Neurons Are Sensors of Mast Cell-Induced Itch.
    Solinski HJ; Kriegbaum MC; Tseng PY; Earnest TW; Gu X; Barik A; Chesler AT; Hoon MA
    Cell Rep; 2019 Mar; 26(13):3561-3573.e4. PubMed ID: 30917312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
    Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
    Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.